Actavia Life Sciences Inc (RASP) Annual Balance Sheets

Annual · GAAP · USD millions
Access RASP quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Actavia Life Sciences Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Sep 30 2022) (Sep 30 2021) (Sep 30 2020) (Sep 30 2019)
Assets
Cash & cash equivalent0.07
Cash & Short-term Investments0.00
Due from Related Parties, Current RE0.00
Prepaid Expense And Other Assets Current0.02
Total Current Assets0.10
Equipment/Property/Plant Net0.00
Goodwill net0.00
Intangible Assets0.00
Other Assets, Noncurrent0.00
Total Assets0.10
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.46
Derivative Liability, Current DE0.00
Short-term Debt0.20
Other Liabilities, Current0.39
Total Current Liabilities2.05
Long-term debt0.00
Convertible Notes Payable NO0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net, Noncurrent LI0.00
Other liabilities, Noncurrent0.00
Due To Related Partie Current0.00
Total Liabilities2.05
Stockholders' Equity
Common Stock Value0.77
Additional Paid In Capital Common Stock25.94
Retained Earnings / Accumulated Deficit-28.66
Other Equity0.00
Common Stockholder's Equity-1.96
Total Stockholder's Equity-1.96
Liabilities & Stockholder's Equity0.10
4 historic quarters locked

Sign in to unlock the full Actavia Life Sciences Inc balance sheet history.

About Actavia Life Sciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-24-045020

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.